TGTX US,+1

TGTX US,+1

2019-07-03T11:36:10+00:00July 1st, 2019|Stock of the Week|

TG Therapeutics in, (TGTX US, +1) – Michael Weiss (CEO, 2011) purchased $350,000 worth of stock on June 26 at $7.04. Weiss is a “Smart Buyer” and has made two timely purchases in TGTX (Sept. 2012 at $2.25 and Dec. 2013 at $3.43) as well as a timely sale in the stock in December 2014 at $16.44. The stock has almost doubled from the beginning of the year but is still below where Weiss sold shares in 2014. After the 50,000 share purchase, Weiss owns 12.8 million shares (14.6% of the company). We are ranking the stock +1.